Nursing home-acquired pneumonia (NHAP) has been identified as one of the leading causes of mortality and hospitalization for long-term care residents. However, current and previous pneumonia guidelines differ on the appropriate management of NHAP in hospitalized patients, specifically in regard to the role of atypical bacteria such as Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella.
Objectives
The purpose of this review is to evaluate clinical trials conducted in hospitalized patients with NHAP to determine the prevalence of atypical bacteria and thus the role for empiric antibiotic coverage of these pathogens in NHAP.
Methods
Comprehensive MEDLINE (1966-April 2016) and Embase (1980-April 2016) searches were performed using the terms “atypical bacteria”, “atypical pneumonia”, “nursing-home acquired pneumonia”, “pneumonia”, “elderly”, “nursing homes”, and “long term care”. Additional articles were retrieved from the review of references cited in the collected studies. Thirteen published clinical trials were identified.
Results
In the majority of studies, atypical bacteria were infrequently identified in patients hospitalized with NHAP. However, when an active community-acquired pneumonia (CAP) cohort was available, the rate of atypical bacteria between NHAP and CAP study arms was similar. Only 3 studies in this review adhered to recommended strategies for investigating atypical bacteria; in 2 of these studies, C. pneumoniae was the most common pathogen identified in NHAP cohorts.
Conclusion
Although atypical bacteria were uncommon in most NHAP studies in this review, suboptimal microbial investigations were commonly performed. To accurately describe the role of atypical bacteria in NHAP, more studies using validated diagnostic tests are needed.
DhawanN., PandyaN., KhaliliM.Predictors of mortality for nursing home-acquired pneumonia: A systematic review [published online ahead of print March 2, 2015]. Biomed Res Int.
2.
El SolhA.Nursing home-acquired pneumonia. Semin Respir Crit Care Med.2009; 30: 16–25.
3.
NaughtonB., MylotteJ.Treatment guideline for nursing home-acquired pneumonia based on community practice. J Am Geriatr Soc.2000; 48: 82–88.
4.
HuttE., KramerA.M.Evidence-based guidelines for management of nursing-home acquired pneumonia. J Fam Pract.2002; 51: 709–716.
5.
American Thoracic Society.Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med.2001; 163: 1730–1754.
6.
BartlettJ.G., DowellS.F., MandellL.A.Infectious Diseases Society of America. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis.2000; 31: 347–382.
7.
MandellL.A., BartlettJ.G., DowellS.F.Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis.2003; 37: 1405–1433.
8.
American Thoracic Society and Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med.2005; 171: 388–416.
9.
MandellL.A., WunderickR.G., AnzuetoA.Infectious Diseases Society of America/American Thoracic Society. Consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis.2007; 44: S27–72.
10.
El-SolhA.A., SikkaP., RamadanF., DaviesJ.Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med.2001; 163: 645–651.
11.
El-SolhA.A., AquilinaA.T., DhillonR.S., RamadanF., NowakP., DaviesJ.Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med.2002; 166: 1038–1043.
12.
El-SolhA.A., AlhajhusainA., SalibaR.G., DrinkP.Physicians' attitudes toward guidelines for the treatment of hospitalized nursing-home acquired pneumonia. J Am Med Dir Assoc.2011; 12(4): 270–276.
13.
CaseyC., FullertonM., SomervilleN.Common questions about pneumonia in nursing home residents. Am Fam Physician.2015; 92(7): 612–620.
14.
MandellL.A., MarrieT.J., GrossmanR.F., ChowA.W., HylandR.H.Canadian guidelines for the initial management of community-acquired pneumonia: An evidence based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis.2000; 31: 383–421.
15.
LimW.S., BaudouinS.V., GeorgeR.C.British Thoracic Society guidelines for the management of community acquired pneumonia in adults: Update 2009. Thorax.2009; 64(suppl III): iii1–iii55.
16.
National Clinical Guideline Centre (UK).Pneumonia: Diagnosis and Management of Community- and Hospital-Acquired Pneumonia in Adults. Clinical Guideline 191.London: National Institute for Health and Care Excellence;2014.
17.
YoshifumiI., YuichiroS., MasafumiS.Clinical practice guidelines for nursing and healthcare-associated pneumonia (NHCAP). Respir Invest.2013; 51: 103–126.
18.
KalilA.C., MeterskyM.L., KlompasM., MuscedreJ., SweeneyD., PalmerL.Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis2016; 63: 1–51.
19.
MuderR.Pneumonia in residents of long-term care facilities: Epidemiology, etiology, management, and prevention. Am J Med.1998; 105: 319–330.
20.
MaruyamaT., NiedermanM.S., KobayashiT.A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med.2008; 102: 1287–1295.
21.
MaruyamaT., NiedermanM.S., KobayashiT.Supplemental material: A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med.2008; 102: 1287–1295.
22.
MaruyamaT., GabazzaE.C., MorserJ.Community-acquired pneumonia and nursing home-acquired pneumonia in very elderly patients. Respir Med.2010; 104: 584–592.
23.
LimW.S., MacfarlaneJ.T.A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J.2001; 18: 362–368.
24.
LimW.S., MacfarlaneJ.T., BoswellT.C.SCAPA. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax.2001; 56: 296–301.
25.
LuiG., IPM., LeeN.Role of “atypical pathogens” among adult hospitalized patients with community-acquired pneumonia. Respirology.2009; 14: 1098–1105.
26.
MaH.M., WahJ.L., WooJ.Should nursing home-acquired pneumonia be treated as nosocomial pneumonia?J Am Med Dir Assoc.2012; 13: 727–731.
27.
MaH.M., IpM., HuiE., ChanP., HuiD., WooJ.Role of atypical pathogens in nursing home-acquired pneumonia. J Am Med Dir Assoc.2013; 14: 109–113.
28.
HuiD.S., WooJ., HuiE.Influenza-like illness in residential care homes: A study of the incidence, aetiological agents, natural history and health resource utilization. Thorax.2008; 63: 690–697.
29.
EwigS., KlapdorB., PletzM.W.Nursing-home acquired pneumonia in Germany: An 8-year prospective multicentre study. Thorax.2012; 67: 132–138.
Von BaumH., WelteT., MarreR., SuttorpN., LuckC., EwigS.Mycoplasma pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis.2009; 9: 62.
32.
KohS.J., LeeJ.H.Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital. Korean J Intern Med.2015; 30: 638–647.
33.
PolverinoE., DambravaP., CillonizC.Nursing home acquired pneumonia: A 10 year single-centre experience. Thorax.2010; 65: 354–359.
34.
UmekiK., TokimatsuI., YasudaC.Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: Comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology.2011; 16: 856–861.
35.
MiyashitaN., KawaiY., AkaikeH.Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): Differences between a teaching university hospital and a community hospital. Intern Med.2012; 51(6): 585–594.
36.
DowellS.F., PeelingR.W., BomanJ.Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Di.s2001; 33: 492–503.
37.
LoensK.Acute respiratory infection due to Mycoplasma pneumoniae: Current status of diagnostic methods. Eur J Clin Microbiol Infect Dis.2010; 29(9): 1055–1069.
UtsumiM., MakimotoK., QuroshiN., AshidaN.Types of infectious outbreaks and their impact in elderly care facilities: A review of the literature. Age Aging.2010; 39: 299–305.
40.
TroyC.J., PeelingR.W., EllisA.G.Chlamydia pneumonia as a new source of infectious outbreaks in nursing homes. JAMA.1997; 277: 1214–1218.
41.
NakashimaK., TanakaT., KramerM.H.Outbreak of Chlamydia pneumonia infection in a Japanese nursing home. Infect Control Hosp Epidemiol.2006; 27: 1171–1177.
42.
MiyashitaN., OuchiK., ShojiH.Outbreak of Chlamydophilia pneumonia infection in long-term care facilities and an affiliated hospital. J Med Microbiol.2005; 54: 1243–1247.
43.
BrennenC., VickersR.M., YuV.L.Discovery of occult legionella pneumonia in long stay hospital; results of prospective serological survey. BMJ.1987; 295: 306–307.
44.
MaesakiS., KohnoS., KogH.An outbreak of legionnaires' pneumonia in a nursing home. Intern Med.1992; 31: 508–512.
45.
NechwatalR., EhretW., KlatteO.J.Nosocomial outbreak of legionellosis in a rehabilitation center. Demonstration of potable water as a source. Infection.1993; 21: 235–340.
46.
LoebM., SimorA.E., MandellL.Two nursing home outbreaks of respiratory infections with Legionella sainthelensi. J Am Geriatr Soc.1999; 47: 547–552.
47.
SeenivasanM.H., YuV.L., MuderR.R.Legionnaires' disease in long-term care facilities: Overview and proposed solutions. J Am Geriatr Soc.2005; 53: 875–880.
48.
PharesC.R., RussellE., ThigpenM.C.Legionnaires' disease among residents of a long–term care facility: The sentinel event in a community outbreak. Am J Infect Control.2007; 35: 319–323.
49.
HastingsD.L., HarringtonK.J., KuttyP.K., RaymanR.J., SpindolaD., DiazM.H.Mycoplasma pneumoniae outbreak in a long-term care facility—Nebraska 2014. MMWR Morb Mortal Wkly Rep.2015; 64(11): 296–299.
50.
GarinN., GenneD., SebastianC.β-lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: A randomized noninferiority trial. JAMA Intern Med.2014; 174(12): 1894–1901.
51.
SocanM., KosmeljN., Marinic-FiserN., VidmarL.A prediction model for community-acquired Chlamydia pneumniae pneumonia in hospitalized patients. Infection.2004; 32: 204–209.
